0 Commentaires
0 Parts
256 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Hedgehog Pathway Inhibitor Drug Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Hedgehog Pathway Inhibitor Drug Market The global hedgehog pathway inhibitor drug market size was valued at USD 1.35 billion in 2025 and is expected to reach USD 3.24 billion by 2033, at a CAGR of 11.60% during the forecast period The reliable Hedgehog Pathway Inhibitor Drug...0 Commentaires 0 Parts 200 Vue 0 Aperçu
-
HER2 Positive Breast Cancer Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period For structuring the finest market...0 Commentaires 0 Parts 320 Vue 0 Aperçu
-
HER2 Positive Breast Cancer Treatment Market Growth, Targeted Oncology Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period Getting thoughtful about competitive...0 Commentaires 0 Parts 230 Vue 0 Aperçu
-
HER2 Positive Breast Cancer Treatment Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period The HER2 Positive Breast Cancer...0 Commentaires 0 Parts 304 Vue 0 Aperçu
-
HER2+ Gastric Cancer Market Advances with Targeted Therapy Innovations and Precision Oncology DevelopmentsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% This global HER2+ Gastric Cancer Market report is a wonderful...0 Commentaires 0 Parts 222 Vue 0 Aperçu
-
MET Inhibitor Drug Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the MET Inhibitor Drug Market The global MET Inhibitor Drug market size was valued at USD 1.89 billion in 2025 and is expected to reach USD 5.94 billion by 2033, at a CAGR of 15.40% during the forecast period This global MET Inhibitor Drug Market report is a wonderful guide to...0 Commentaires 0 Parts 229 Vue 0 Aperçu
-
Vascular Endothelial Growth Factor VEGF Inhibitor Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Data Bridge Market Research analyses a growth rate in the vascular endothelial growth factor (VEGF) inhibitor market in the forecast period 2023-2030. The expected CAGR of vascular endothelial growth factor (VEGF) inhibitor market is tend to be...0 Commentaires 0 Parts 211 Vue 0 Aperçu
-
Vascular Endothelial Growth Factor VEGF Inhibitor Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Data Bridge Market Research analyses a growth rate in the vascular endothelial growth factor (VEGF) inhibitor market in the forecast period 2023-2030. The expected CAGR of vascular endothelial growth factor (VEGF) inhibitor market is tend to be...0 Commentaires 0 Parts 222 Vue 0 Aperçu
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Driving Growth & Opportunities in the Global Oncology Small Molecule Drugs Market Through 2031The Oncology Small Molecule Drugs Market is witnessing transformative growth as pharmaceutical innovation accelerates to address the global cancer burden. With therapeutics that can penetrate cellular targets, modulate intracellular pathways, and be administered orally, small molecule oncology drugs are becoming essential components of cancer treatment regimens worldwide. The Oncology Small...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Oncology Drugs Market to Reach USD 503.13 Billion by 2033, Growing at 11.6% CAGRMarket Overview The global oncology drugs market size was valued at USD 193.04 billion in 2024 and is projected to grow from USD 209.57 billion in 2025 to USD 503.13 billion by 2033, exhibiting a CAGR of 11.6% during the forecast period (2025-2033). The global Oncology Drugs market is witnessing swift transformation driven by new consumer behaviors, increased...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek